DBV Technologies | DBVT - Reddito Netto





Reddito Netto Cambiamento Data
Acadia Pharmaceuticals USD 3.64M 269.93M 2026-03
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Amarin USD -1.22M 6.51M 2025-12
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
DBV Technologies USD -33.16M 8.71M 2025-09
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Galectin Therapeutics USD -12.37M 880K 2024-06
Halozyme Therapeutics USD 150.05M 291.64M 2026-03
Incyte USD 303.33M 4.05M 2026-03
Insmed USD -163.56M 164.92M 2026-03
Ionis Pharmaceuticals USD -93M 136M 2026-03
Neurocrine Biosciences USD 197.9M 44.2M 2026-03
PTC Therapeutics USD -2.81M 132.16M 2026-03
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
United Therapeutics USD 274.9M 89.4M 2026-03